Operation and seizure outcome
| Oligodendrocytosis (n = 18) | FCD I (n = 21) | Oligodendrocytosis + FCD I (n = 7) | P Value | |
|---|---|---|---|---|
| Invasive monitoring | .09 | |||
| Yes (%) | 10 (55.6) | 15 (71.4) | 7 (100) | |
| No (%) | 8 (44.4) | 6 (28.6) | 0 (0) | |
| Extension of resection | .37 | |||
| Unilobar (%) | 10 (55.6) | 7 (33.3) | 3 (42.9) | |
| Multilobar (%) | 8 (44.4) | 12 (57.2) | 4 (57.1) | |
| Hemispherectomy (%) | 0 (0) | 2 (9.5) | 0 (0) | |
| Location of operation | .10 | |||
| Temporal (%) | 8 (44.4) | 3 (14.3) | 0 (0) | |
| Temporal and extratemporal (%) | 7 (38.9) | 11 (52.4) | 4 (57.1) | |
| Extratemporal (%) | 3 (16.7) | 7 (33.3) | 3 (42.9) | |
| Seizure outcome at 1 yr | .58 | |||
| Seizure-free (ILAE) I (%) | 13 (72.2) | 12 (57.1) | 4 (57.1) | |
| Persistent seizures (ILAE II–VI) (%) | 5 (27.8) | 9 (42.9) | 3 (42.9) | |
| Seizure outcome at 1 yr | .35 | |||
| ILAE (I–IV) | 18 (100) | 16 (76.2) | 7 (100) | |
| ILAE (V–VI) | 0 (0) | 5 (23.8) | 0 (0) |